Assessment of Activities of Daily Living in Adults With Chronic Low Back Pain Using a Nonoperative Treatment Modality
1 other identifier
observational
116
0 countries
N/A
Brief Summary
The investigators hypothesize that treatment with non-invasive spinal decompression reduces discogenic low back pain (LBP), decreases visual analog pain scale scores, increases activities of daily living and decreases medication use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2014
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 22, 2016
CompletedFirst Posted
Study publicly available on registry
April 6, 2016
CompletedApril 6, 2016
March 1, 2016
1.7 years
March 22, 2016
April 5, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Lower back pain measured on an 11-point numeric rating scale (VAS) with 0 reflecting no pain at all and 10 the worst imaginable pain.
0= no pain; 10=worst pain
12-16 weeks
Secondary Outcomes (2)
Functional capacity, measured by activities of daily living
12-16 weeks
Proportion of patients using adjuvant analgesic medication
12-16 weeks
Interventions
Eligibility Criteria
Pain Management Clinic
You may qualify if:
- at least 18 years of age;
- consented to the physician prescribed protocol;
- presented with discogenic low back pain defined as low back pain for minimum of 12 weeks;
- current CT scan
You may not qualify if:
- metastatic cancer;
- previous spinal fusion or placement of stabilization hardware within 6 months;
- instrumentation or artificial discs;
- neurologic motor deficits, bladder, or sexual dysfunction;
- alcohol or drug abuse
- patient's with extremes of height (\< 147 cm or \> 203 cm) and body weight (\> 136 kg).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2016
First Posted
April 6, 2016
Study Start
February 1, 2014
Primary Completion
November 1, 2015
Study Completion
March 1, 2016
Last Updated
April 6, 2016
Record last verified: 2016-03